NYSE:RBOT Vicarious Surgical (RBOT) Stock Price, News & Analysis → Digitizing the $11T commodities sector with one tiny stock (From Resource Stock Digest) (Ad) Free RBOT Stock Alerts $0.33 -0.02 (-5.69%) (As of 05/28/2024 ET) Add Compare Share Share Today's Range$0.33▼$0.3750-Day Range$0.25▼$0.4352-Week Range$0.20▼$2.37Volume465,772 shsAverage Volume587,073 shsMarket Capitalization$48.85 millionP/E RatioN/ADividend YieldN/APrice Target$0.67 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Get Vicarious Surgical alerts: Email Address Vicarious Surgical MarketRank™ Stock AnalysisAnalyst RatingHold2.00 Rating ScoreUpside/Downside101.4% Upside$0.67 Price TargetShort InterestHealthy3.54% of Shares Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment-1.01Based on 3 Articles This WeekInsider TradingSelling Shares$23,147 Sold Last QuarterProj. Earnings GrowthDecreasingFrom ($0.36) to ($0.41) Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.1.90 out of 5 starsMedical Sector824th out of 931 stocksSurgical Appliances & Supplies Industry17th out of 18 stocks 3.0 Analyst's Opinion Consensus RatingVicarious Surgical has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no buy ratings, 4 hold ratings, and no sell ratings.Amount of Analyst CoverageVicarious Surgical has only been the subject of 1 research reports in the past 90 days.Read more about Vicarious Surgical's stock forecast and price target. Previous Next 4.0 Short Interest Percentage of Shares Shorted3.54% of the outstanding shares of Vicarious Surgical have been sold short.Short Interest Ratio / Days to CoverVicarious Surgical has a short interest ratio ("days to cover") of 8.7.Change versus previous monthShort interest in Vicarious Surgical has recently decreased by 21.18%, indicating that investor sentiment is improving significantly. Previous Next 0.0 Dividend Strength Dividend YieldVicarious Surgical does not currently pay a dividend.Dividend GrowthVicarious Surgical does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for RBOT. Previous Next 1.1 News and Social Media Coverage News SentimentVicarious Surgical has a news sentiment score of -1.01. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.92 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 3 news articles for Vicarious Surgical this week, compared to 1 article on an average week.Search Interest10 people have searched for RBOT on MarketBeat in the last 30 days. This is an increase of 150% compared to the previous 30 days.MarketBeat FollowsOnly 1 people have added Vicarious Surgical to their MarketBeat watchlist in the last 30 days. This is a decrease of -80% compared to the previous 30 days. Previous Next 2.5 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Vicarious Surgical insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $23,147.00 in company stock.Percentage Held by Insiders11.73% of the stock of Vicarious Surgical is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions47.27% of the stock of Vicarious Surgical is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Vicarious Surgical's insider trading history. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for Vicarious Surgical are expected to decrease in the coming year, from ($0.36) to ($0.41) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Vicarious Surgical is -0.87, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Vicarious Surgical is -0.87, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioVicarious Surgical has a P/B Ratio of 0.59. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.Read more about Vicarious Surgical's valuation and earnings. Previous Next See Top Rated MarketRank™ Stocks Here Ad WealthPressThis TSLA short trade is on a nine win hot streakMost Tesla Shareholders are disappointed in the stock's performance in 2024. Year to date, it's down 30%... And things don’t seem to be getting better. That said, one professional trader has found a way to turn Tesla’s demise into a flurry of opportunity… In fact, he has not lost a single trade on Tesla this year. As of this mailing he’s 9 for 9 with incredible wins under his belt. Just see for yourself.But I can promise that you’ll see all the details for yourself here. About Vicarious Surgical Stock (NYSE:RBOT)Vicarious Surgical Inc. operates as a robotics technology company in the United States. The company focuses on developing and commercializing Vicarious System, a single-incision surgical robot that virtually transports surgeons inside the patient to perform minimally invasive surgery. Vicarious Surgical Inc. was incorporated in 2014 and is headquartered in Waltham, Massachusetts.Read More RBOT Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart RBOT Stock News HeadlinesMay 28 at 1:42 AM | americanbankingnews.comVicarious Surgical (NYSE:RBOT) Stock Price Down 6.2%May 3, 2024 | yahoo.comRevolutionizing surgery: Tacoma hospital unveils state-of-the-art surgical robotMay 1, 2024 | msn.comVicarious Surgical Inc. (NYSE:RBOT) Q1 2024 Earnings Call TranscriptApril 30, 2024 | yahoo.comNew robot helping improve surgeries at Sharp HospitalApril 30, 2024 | finance.yahoo.comVicarious Surgical Inc (RBOT) (Q1 2024) Earnings Call Transcript Highlights: Strategic Cost ...April 29, 2024 | investorplace.comRBOT Stock Earnings: Vicarious Surgical Meets EPS for Q1 2024April 29, 2024 | msn.comSOVAH Health makes surgical advancement with new robotApril 12, 2024 | msn.comRobots in the operating room — and moreApril 8, 2024 | businesswire.comVicarious Surgical to Report First Quarter 2024 Financial Results on April 29, 2024March 25, 2024 | hk.finance.yahoo.comInsiders Give Up US$335k As Vicarious Surgical Stock Drops To US$0.34March 23, 2024 | investing.comVicarious Surgical CTO sells shares worth over $1300March 23, 2024 | investing.comVicarious Surgical CFO sells shares to cover tax obligationsMarch 20, 2024 | seekingalpha.comRBOT Vicarious Surgical Inc.March 12, 2024 | msn.comRobotic interface masters a soft touchMarch 7, 2024 | investing.comVicarious Surgical earnings beat by $0.06, revenue was in line with estimatesMarch 6, 2024 | seekingalpha.comVicarious Surgical Inc. (RBOT) Q4 2023 Earnings Call TranscriptMarch 5, 2024 | au.finance.yahoo.comQ4 2023 Vicarious Surgical Inc Earnings CallMarch 5, 2024 | finance.yahoo.comVicarious Surgical Inc. (NYSE:RBOT) Q4 2023 Earnings Call TranscriptMarch 5, 2024 | markets.businessinsider.comVicarious Surgical (RBOT) Gets a Hold from BTIGMarch 4, 2024 | marketwatch.comVicarious Surgical Chairman David Styka ResignsMarch 4, 2024 | businesswire.comVicarious Surgical Reports Fourth Quarter and Full Year 2023 Financial ResultsFebruary 22, 2024 | benzinga.comVicarious Surgical Stock (NYSE:RBOT), Short Interest ReportFebruary 20, 2024 | finance.yahoo.comVicarious Surgical to Participate in TD Cowen’s 44th Annual Healthcare ConferenceFebruary 20, 2024 | businesswire.comVicarious Surgical to Participate in TD Cowen's 44th Annual Healthcare ConferenceFebruary 17, 2024 | finance.yahoo.comRBOT Apr 2024 2.500 putSee More Headlines Receive RBOT Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Vicarious Surgical and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings4/29/2024Today5/28/2024Next Earnings (Estimated)7/25/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorMedical Industry Surgical appliances & supplies Sub-IndustryN/A Current SymbolNYSE:RBOT CUSIPN/A CIK1812173 Webwww.vicarioussurgical.com Phone617 868 1700FaxN/AEmployees3Year FoundedN/APrice Target and Rating Average Stock Price Target$0.67 High Stock Price Target$1.00 Low Stock Price Target$0.40 Potential Upside/Downside+90.4%Consensus RatingHold Rating Score (0-4)2.00 Research Coverage4 Analysts Profitability EPS (Most Recent Fiscal Year)($0.38) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-71,070,000.00 Net MarginsN/A Pretax MarginN/A Return on Equity-77.20% Return on Assets-61.12% Debt Debt-to-Equity RatioN/A Current Ratio17.16 Quick Ratio17.16 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value$0.56 per share Price / Book0.63Miscellaneous Outstanding Shares147,220,000Free Float129,948,000Market Cap$51.56 million OptionableOptionable Beta1.16 The Best High-Yield Dividend Stocks for 2024Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.Get This Free Report Key CompetitorsLakeland IndustriesNASDAQ:LAKECollPlant BiotechnologiesNASDAQ:CLGNAlpha Pro TechNYSE:APTMilestone ScientificNYSE:MLSSNutribandNASDAQ:NTRBView All CompetitorsInsiders & InstitutionsAdam David SachsSold 24,502 sharesTotal: $9,555.78 ($0.39/share)Sammy KhalifaSold 19,601 sharesTotal: $7,644.39 ($0.39/share)William John KellySold 6,546 sharesTotal: $2,552.94 ($0.39/share)Jacobs Levy Equity Management Inc.Sold 866,631 shares on 5/16/2024Ownership: 0.136%Adam David SachsSold 4,830 sharesTotal: $1,642.20 ($0.34/share)View All Insider TransactionsView All Institutional Transactions RBOT Stock Analysis - Frequently Asked Questions Should I buy or sell Vicarious Surgical stock right now? 4 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Vicarious Surgical in the last twelve months. There are currently 4 hold ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" RBOT shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in RBOT, but not buy additional shares or sell existing shares. View RBOT analyst ratings or view top-rated stocks. What is Vicarious Surgical's stock price target for 2024? 4 brokerages have issued 12 month price targets for Vicarious Surgical's stock. Their RBOT share price targets range from $0.40 to $1.00. On average, they anticipate the company's share price to reach $0.67 in the next twelve months. This suggests a possible upside of 101.4% from the stock's current price. View analysts price targets for RBOT or view top-rated stocks among Wall Street analysts. How have RBOT shares performed in 2024? Vicarious Surgical's stock was trading at $0.3667 at the beginning of 2024. Since then, RBOT stock has decreased by 9.7% and is now trading at $0.3310. View the best growth stocks for 2024 here. Are investors shorting Vicarious Surgical? Vicarious Surgical saw a decrease in short interest in the month of May. As of May 15th, there was short interest totaling 5,210,000 shares, a decrease of 21.2% from the April 30th total of 6,610,000 shares. Based on an average daily trading volume, of 596,300 shares, the short-interest ratio is presently 8.7 days. View Vicarious Surgical's Short Interest. When is Vicarious Surgical's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Thursday, July 25th 2024. View our RBOT earnings forecast. How were Vicarious Surgical's earnings last quarter? Vicarious Surgical Inc (NYSE:RBOT) released its quarterly earnings results on Monday, April, 29th. The company reported ($0.09) EPS for the quarter, beating the consensus estimate of ($0.10) by $0.01. Who are Vicarious Surgical's major shareholders? Vicarious Surgical's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Jacobs Levy Equity Management Inc. (0.14%). Insiders that own company stock include Adam David Sachs, John Mazzola, June Morris, Philip Liang, Sammy Khalifa, Ventures V LP Khosla and William John Kelly. View institutional ownership trends. How do I buy shares of Vicarious Surgical? Shares of RBOT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NYSE:RBOT) was last updated on 5/28/2024 by MarketBeat.com Staff From Our PartnersDems have chosen Biden replacement?Paradigm PressCrypto Pioneer Says: “The last crypto bull market has begun.”InvestorPlaceDigitizing the $11T commodities sector with one tiny stockResource Stock DigestTim Sykes’ Urgent Trade Alert: “Make this move now”Timothy SykesPresident Biden just made a shocking moveStansberry ResearchExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersHe Is Giving Away BitcoinCrypto Swap ProfitsThe #1 Crypto for AIWeiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Vicarious Surgical Inc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
